|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1998-8-13
|
|
pubmed:abstractText |
To evaluate the efficacy and toxicity of single-agent docetaxel in patients with metastatic urothelial carcinoma and impaired renal function.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0090-4295
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
56-60
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9671871-Aged,
pubmed-meshheading:9671871-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9671871-Carcinoma, Transitional Cell,
pubmed-meshheading:9671871-Female,
pubmed-meshheading:9671871-Humans,
pubmed-meshheading:9671871-Kidney Diseases,
pubmed-meshheading:9671871-Male,
pubmed-meshheading:9671871-Middle Aged,
pubmed-meshheading:9671871-Paclitaxel,
pubmed-meshheading:9671871-Taxoids
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Treatment of patients with metastatic urothelial carcinoma and impaired renal function with single-agent docetaxel.
|
|
pubmed:affiliation |
Department of Clinical Therapeutics, University of Athens School of Medicine, Greece.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
